Intervention

Siplizumab

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

1 shown

Siplizumab in T1DMNCT05574335 · 2023-05-18

TERMINATED

Common conditions

Type 1 Diabetes Mellitus1

Leading sponsors

National Institute of Allergy and Infectious Diseases (NIAID)1

Trial status mix

TERMINATED1

Phase mix

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.